Page last updated: 2024-09-04

cyc 202 and Liver Diseases

cyc 202 has been researched along with Liver Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bukanov, NO; Galons, H; Ibraghimov-Beskrovnaya, O; Ledbetter, SR; Meijer, L; Moreno, SE; Natoli, TA; Oumata, N; Rogers, KA; Smith, LA	1

Other Studies

1 other study(ies) available for cyc 202 and Liver Diseases

Article	Year
CDK inhibitors R-roscovitine and S-CR8 effectively block renal and hepatic cystogenesis in an orthologous model of ADPKD. Cell cycle (Georgetown, Tex.), 2012, Nov-01, Volume: 11, Issue:21 Topics: Adenine; Animals; Apoptosis; Cyclin-Dependent Kinases; Disease Models, Animal; Humans; Kidney Diseases, Cystic; Liver Diseases; Mice; Mice, Knockout; Polycystic Kidney, Autosomal Dominant; Protein Kinase C; Protein Kinase Inhibitors; Purines; Roscovitine	2012

Article

Year

CDK inhibitors R-roscovitine and S-CR8 effectively block renal and hepatic cystogenesis in an orthologous model of ADPKD.

Cell cycle (Georgetown, Tex.), 2012, Nov-01, Volume: 11, Issue:21

Topics: Adenine; Animals; Apoptosis; Cyclin-Dependent Kinases; Disease Models, Animal; Humans; Kidney Diseases, Cystic; Liver Diseases; Mice; Mice, Knockout; Polycystic Kidney, Autosomal Dominant; Protein Kinase C; Protein Kinase Inhibitors; Purines; Roscovitine

2012